Qualisure Diagnostics Inc. (Accelerator)

Company Description: Qualisure is a developer of genomics-based precision diagnostic products. Our products are designed to guide physicians and patients to more precise decisions about the treatment of cancer, avoiding unnecessary or unbeneficial treatments. Our products have been developed using a machine learning algorithm to examine the genomic information of cancer populations, producing proprietary biomarkers to distinguish aggressive cancers from more indolent ones. This aids physicians to select the least toxic and least invasive treatments possible while maintaining the lowest possible risk of tumor recurrence. Our first clinical test, Thyroid GuidePx™, accurately categorizes papillary thyroid cancer patients according to the risk of recurrence so that treating physicians and surgeons can create a treatment plan aligned with each patient's personal genomic information rather than general clinical guidelines. The value proposition to clinicians treating thyroid cancer is substantial, as there is a significant opportunity to reduce overtreatment. The need for a molecular prognostic test is great, as there are no other tests like it on the market.